Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

236 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Durability of Near-Complete Skin Clearance in Patients with Psoriasis Using Systemic Biologic Therapies: Real-World Evidence from the CorEvitas Psoriasis Registry.
McLean RR, Sima AP, Beaty S, Jones EA, Eckmann T, Low R, McClung L, Spitzer RL, Stark J, Armstrong A. McLean RR, et al. Among authors: spitzer rl. Dermatol Ther (Heidelb). 2023 Nov;13(11):2753-2768. doi: 10.1007/s13555-023-01028-5. Epub 2023 Sep 27. Dermatol Ther (Heidelb). 2023. PMID: 37759099 Free PMC article.
Clinical Characteristics of Registry Participants with Psoriatic Arthritis Initiating Guselkumab: An Analysis from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.
Mease PJ, Ogdie A, Chakravarty SD, Shiff NJ, Lin I, McLean RR, Malley W, Spitzer RL, Kavanaugh A, Merola JF. Mease PJ, et al. Among authors: spitzer rl. Drugs Real World Outcomes. 2022 Dec;9(4):617-628. doi: 10.1007/s40801-022-00326-2. Epub 2022 Oct 15. Drugs Real World Outcomes. 2022. PMID: 36243860 Free PMC article.
Impact of difficult biliary cannulation on post-ERCP pancreatitis: secondary analysis of the stent versus indomethacin trial dataset.
Han S, Zhang J, Durkalski-Mauldin V, Foster LD, Serrano J, Coté GA, Bang JY, Varadarajulu S, Singh VK, Khashab M, Kwon RS, Scheiman JM, Willingham FF, Keilin SA, Groce JR, Lee PJ, Krishna SG, Chak A, Slivka A, Mullady D, Kushnir V, Buxbaum J, Keswani R, Gardner TB, Wani S, Edmundowicz SA, Shah RJ, Forbes N, Rastogi A, Ross A, Law J, Yachimski P, Chen YI, Barkun A, Smith ZL, Petersen BT, Wang AY, Saltzman JR, Spitzer RL, Spino C, Elmunzer BJ, Papachristou GI; SVI Study Group. Han S, et al. Among authors: spitzer rl. Gastrointest Endosc. 2024 Oct 9:S0016-5107(24)03548-X. doi: 10.1016/j.gie.2024.10.003. Online ahead of print. Gastrointest Endosc. 2024. PMID: 39389431
Technical Factors Associated With the Benefit of Prophylactic Pancreatic Stent Placement During High-Risk Endoscopic Retrograde Cholangiopancreatography: A Secondary Analysis of the SVI Trial Data Set.
Elmunzer BJ, Zhang J, Coté GA, Edmundowicz SA, Wani S, Shah R, Bang JY, Varadarajulu S, Singh VK, Khashab M, Kwon RS, Scheiman JM, Willingham FF, Keilin SA, Papachristou GI, Chak A, Slivka A, Mullady D, Kushnir V, Buxbaum J, Keswani R, Gardner TB, Forbes N, Rastogi A, Ross A, Law J, Yachimski P, Chen YI, Barkun A, Smith ZL, Serrano J, Petersen B, Wang AY, Saltzman JR, Spitzer RL, Ordiah C, Spino C, Foster LD, Durkalski-Mauldin V; SVI Study Group*. Elmunzer BJ, et al. Among authors: spitzer rl. Am J Gastroenterol. 2024 Aug 27. doi: 10.14309/ajg.0000000000003052. Online ahead of print. Am J Gastroenterol. 2024. PMID: 39207308
Trainee Participation and Outcomes in High-risk Endoscopic Retrograde Cholangiopancreatography: A Secondary Analysis of the Stent Versus Indomethacin Trial.
Wani S, Zhang J, Foster LD, Durkalski-Mauldin V, Elmunzer BJ; Stent Versus Indomethacin (SVI) Study Group. Wani S, et al. Clin Gastroenterol Hepatol. 2024 Jul 31:S1542-3565(24)00680-3. doi: 10.1016/j.cgh.2024.06.046. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 39089516 No abstract available.
Indomethacin with or without prophylactic pancreatic stent placement to prevent pancreatitis after ERCP: a randomised non-inferiority trial.
Elmunzer BJ, Foster LD, Serrano J, Coté GA, Edmundowicz SA, Wani S, Shah R, Bang JY, Varadarajulu S, Singh VK, Khashab M, Kwon RS, Scheiman JM, Willingham FF, Keilin SA, Papachristou GI, Chak A, Slivka A, Mullady D, Kushnir V, Buxbaum J, Keswani R, Gardner TB, Forbes N, Rastogi A, Ross A, Law J, Yachimski P, Chen YI, Barkun A, Smith ZL, Petersen B, Wang AY, Saltzman JR, Spitzer RL, Ordiah C, Spino C, Durkalski-Mauldin V; SVI Study Group. Elmunzer BJ, et al. Among authors: spitzer rl. Lancet. 2024 Feb 3;403(10425):450-458. doi: 10.1016/S0140-6736(23)02356-5. Epub 2024 Jan 11. Lancet. 2024. PMID: 38219767 Clinical Trial.
Association Between Preadmission Acid Suppressive Medication Exposure and Severity of Illness in Patients Hospitalized With COVID-19.
Elmunzer BJ, Wolf BJ, Scheiman JM, Tierney WM, Taylor JR; North American Alliance for the Study of Digestive Manifestations of COVID-19. Elmunzer BJ, et al. Gastroenterology. 2021 Mar;160(4):1417-1422.e14. doi: 10.1053/j.gastro.2020.11.007. Epub 2020 Nov 12. Gastroenterology. 2021. PMID: 33189702 Free PMC article. No abstract available.
236 results